Tenax Therapeutics (TENX) EBITDA Margin (2009 - 2022)
Tenax Therapeutics (TENX) recorded EBITDA Margin of 791935.75% in Q3 2022, up 595394.58 percentage points from the prior quarter.
Powered by 
Analysis
Tenax Therapeutics (TENX) EBITDA Margin (2009 - 2022) Analysis & Trends
On a TTM basis, Tenax Therapeutics' EBITDA Margin came in at -1205422.78% as of Sep 30, 2022, down 3286279.83 percentage points year-over-year; for FY2021, it came in at -3426174.18%, down 4029357.14 percentage points from FY2020.
- Across earlier years, EBITDA Margin came in at 603182.96% in FY2020.
- The Q3 2022 figure is the highest quarterly EBITDA Margin since Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Tenax Therapeutics | 76.96 Mn | -371.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 799,275.27% |
| Jun 30, 2022 | 196,541.17% |
| Mar 31, 2022 | 107,170.70% |
| Jun 30, 2021 | 592,310.12% |
| Mar 31, 2021 | 3,879,263.46% |
| Dec 31, 2020 | 468,537.81% |
| Sep 30, 2020 | 369,510.00% |
| Jun 30, 2020 | 535,089.16% |
| Jan 31, 2014 | 5,894.56% |
| Oct 31, 2013 | 3,862.88% |
| Jul 31, 2013 | 981.22% |
| Apr 30, 2013 | -661.55% |
| Jan 31, 2013 | -699.02% |
| Oct 31, 2012 | 530.40% |
| Jul 31, 2012 | -1,843.25% |
| Apr 30, 2012 | -1,909.76% |
| Jan 31, 2012 | -1,231.94% |
| Oct 31, 2011 | -2,129.53% |
| Jul 31, 2011 | -9,395.75% |
| Apr 30, 2011 | 6,278.37% |
API Access
Tenax Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TENX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TENX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TENX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();